Eli Lilly Buys Immunotherapy Cancer Treatment Company for $1.6 Billion

Eli Lilly and Co. is buying ARMO BioSciences Inc. for $1.6 billion in the latest investment in the hot area of immunotherapy cancer treatments.

from WSJ.com: US Business https://ift.tt/2jOmepc
via IFTTT